App-Quantinova.ai

Revascularization Options for Women With Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials

Tayyab Shah - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Impact of Nonrespect of SYNTAX Score II Recommendations for Surgery in Patients With Complex Coronary Artery Disease Treated by PCI: A Pooled Analysis of 3,280 Randomized Patients: SYNTAX, BEST, and PRECOMBAT Trials

Patrick Serruys - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Hydroxyzine

Coronary Artery Perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) study

Tom Ford - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Use of Sirolimus-Coated Balloon in Small Vessel De Novo Lesions: Midterm Follow-Up From a Single-Center Registry

Sandeep Basavarajaiah - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

sirolimus

Midterm Clinical Outcomes Post–Sirolimus-Coated Balloon Angioplasty in Patients With Coronary Artery Disease: Single Center Experience

Sandeep Basavarajaiah - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

sirolimus

Incidence and Outcomes of Bailout Stenting Following Use of Sirolimus Drug-Coated Balloon

Sampath Athukorala - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Myocardial infarction

sirolimus

Incidence and Outcomes of Bailout Stenting Following Use of Drug-Coated Balloon

Sampath Athukorala - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Myocardial infarction

Paclitaxel

Impact of Eligibility Criteria on Clinical Outcomes of Firehawk and XIENCE Coronary Drug-Eluting Stent in an All-Comers Randomized Trial

Yuichi Saito - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

sirolimus

Safety and Clinical Performance of Biodegradable Polymer-Coated Ultrathin Strut Sirolimus-Eluting Stents: 2-Year Outcomes From “Real-World” Patient Population From the T-Flex Registry

Ramesh Babu Pothineni - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Myocardial infarction

sirolimus

Association Between Prediabetes and Clinical Outcomes After Left Main Coronary Artery Revascularization by PCI or CABG: Analysis From the EXCEL Trial

Bjorn Redfors - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Myocardial infarction

Everolimus

Vascular Closure Device Use After PCI for Left Main Disease: Analysis From the EXCEL Trial

Toshiki Kuno - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left main disease

N/A

Impact of Periprocedural Major Adverse Events After PCI and CABG on Long-Term Outcomes in Patients With Left Main Disease: The EXCEL Trial

Sneha Jain - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Post-pericardiotomy syndrome

N/A

Incidence and Clinical Impact of Major Infections Following PCI or CABG for Left Main Disease: Insights From the EXCEL Trial

Rodrigo Modolo - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left main disease

N/A

4-Year Clinical Outcomes in High Bleeding Risk Patients After Surgical or Percutaneous Left Main Coronary Artery Revascularization: The EXCEL Trial

Bimmer Claessen - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left main disease

Everolimus

Spontaneous Myocardial Infarction After Revascularization in Left Main Disease: Analysis From the EXCEL Trial

Mahesh Madhavan - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Incidence and Impact of Major Bleeding Events After PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial

Gennaro Giustino - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left main disease

Aspirin

Inpatient Versus Outpatient PCI in Patients With Left Main Disease: Analysis From the EXCEL Trial

Prakriti Gaba - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

White Blood Cell Count and 4-Year Clinical Outcomes After Left Main Coronary Artery Revascularization: Insights From the EXCEL Trial

Bimmer Claessen - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left main disease

Everolimus

Clinical Outcomes After Left Main Coronary Artery Revascularization by PCI or CABG in Current, Former, and Never Smokers: Analysis From the EXCEL Trial

Bahira Shahim - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Everolimus

Impact of Coronary Artery Dominance on Prognosis After PCI and CABG for Unprotected Left Main Disease: Analysis From the EXCEL Trial

Eisuke Usui - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Everolimus

Filters

45280 Abstracts